| ITM OncoBeta GmbH appoints Mr. Benedikt Stöckert as Managing Director |
| Wednesday, 16 February 2011 10:21 | |
|
Mr. Benedikt Stöckert, who has managed the itm Rhenium SCT development program since 2009 has been appointed managing director (Geschäftsführer) of itm OncoBeta GmbH, effective February 15th, 2011. For further Information please contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it .
|
News
ITG has received the Manufacturing License for Lu-177 n.c.a.As of December 2011, ITG Isotope Technologies Garching GmbH has successfully passed the audit of the GMP production of the...Read more... |
ITG Isotope Technologies Garching GmbH (Germany) announces broad collaboration with ANSTO (Australia) on radioisotopesGarching, Germany, June 3, 2011. ITG Isotope Technologies Garching GmbH (ITG), a specialist in the development and production of innovative...Read more... |
Helmholtz Zentrum München and ITM AG enter antibody dealAscenion has mediated a license agreement between the Helmholtz Zentrum München and ITM Isotopen Technologien München AG providing the company...Read more... |